CRONOS GROUP INC
CRONNASDAQTrading Snapshot
- Day Range
- $405.47 β $412.99
- 52-Week Range
- $2.28 β $3.61
- Volume
- $2.46B
- Avg Volume
- $3.23B
- Shares Outstanding
- 373.7M
- Next Earnings
- Nov 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $149M
- Last Q Revenue
- $71M
- P/E Ratio
- 18.2
- P/S Ratio
- 7.1x
- EPS (TTM)
- $0.19
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β0.3%
Why Investors Own CRON
- βHigh-growth profile β revenue up +49.4% YoY with expanding US Equity exposure.
- βHealthy economics β 39% gross margin and 17% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CRONOS GROUP INC
CRONAbout CRONOS GROUP INC
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
CRONOS GROUP INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift CRON price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CRONOS GROUP INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.